Page 5 - Programmed Cell Death News Today

Mitochondria -; the organelles responsible for energy production in human cells -; were once free-living organisms that found their way into early eukaryotic cells over a billion years ago.

New research from Cornell offers insights into a line of CRISPR systems, which could lead to promising antiviral and tissue engineering tools in animal and plants.

Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.

The article, published in the journal Redox Biology by the group of Dr. Manel Esteller, shows that epigenetic changes prevent iron-associated programmed cell death in leukemia and show a new target for treatment with experimental drugs.

From artificial ligaments and a novel approach to cancer treatment to “soft” batteries and a way to give voice to silent speech, new innovations from UC Berkeley faculty are getting a big vote of support from the Bakar Fellows program.

Programmed cell death is an important tool that an organism uses to keep itself healthy. When a cell does not function as it should, various stress reactions are activated. The goal of these reactions is to restore the original cell function.

Researchers evaluated biomarkers that could help identify COVID-19 patients needing invasive mechanical ventilation.

A research team led by scientists at Albert Einstein College of Medicine has devised a novel and highly promising strategy for overcoming a key cause of cancer deaths: the ability of cancer cells to thrive in the face of chemotherapy drugs designed to destroy them.

Highlights Team IDs cancer-fighting molecule in a preclinical model of pancreatic cancer MMRi62 kills cancer cells through a pathway that depends on iron Discovery could lead to the development of new drugs for pancreatic cancer.

Researchers from different countries performed a meta-analysis of real-world cross-cohorts and provided an association of the gut microbiome with immune checkpoint inhibitors response in patients with advanced melanomas.